Allergic Bronchopulmonary Aspergillosis - 16 Studies Found
| Completed | 
                                    : Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis : : 2025-11-04  | 
                                
| Active, not recruiting | 
                                    : Protocol TARC-ABPA : Allergic Broncho-Pulmonary Aspergillosis : 2012-10-15 : Other: Study of predictive factors Phase 1 : Inclusion of  | 
                                
| Completed | 
                                    : Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis : Allergic Bronchopulmonary Aspergillosis : 2012-06-12 : 
  | 
                                
| Not yet recruiting | 
                                    : A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma : Allergic Bronchopulmonary Aspergilloses : 2017-04-21 : 
  | 
                                
| Completed | 
                                    : A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis : Allergic Bronchopulmonary Aspergillosis : 2015-05-01 : 
  | 
                                
| Completed | 
                                    : Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis : Allergic Bronchopulmonary Aspergillosis : 2011-03-23 : 
  | 
                                
| Completed | 
                                    : A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis : Allergic Bronchopulmonary Aspergillosis : 2013-05-13 : 
  | 
                                
| Completed | 
                                    : Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis : 
 : 2010-10-14 : Dietary Supplement: cholecalciferol (Vitamin D3) 4,000 IU of cholecalciferol (Vitamin D3) orally every d  | 
                                
| Enrolling by invitation | 
                                    : Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded). : Allergic Bronchopulmonary Aspergillosis : 2014-10-22 : 
  | 
                                
| Completed | 
                                    : Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA : 
 : 2008-01-01  |